PDF herunterladen
Semin Respir Crit Care Med 2015; 36(02): 251-266
DOI: 10.1055/s-0035-1546820
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Airway Clearance Strategies in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis

Eleanor Main
1   Physiotherapy Section, RCCA, UCL Institute of Child Health, London, United Kingdom
,
Lizzie Grillo
1   Physiotherapy Section, RCCA, UCL Institute of Child Health, London, United Kingdom
2   Department of Physiotherapy, Royal Brompton Hospital, London, United Kingdom
,
Sarah Rand
1   Physiotherapy Section, RCCA, UCL Institute of Child Health, London, United Kingdom
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
31. März 2015 (online)

    Lizenzen und Reprints

Abstract

Many patients with cystic fibrosis (CF) and non-CF bronchiectasis present with common symptoms in clinical domains that appear to benefit from airway clearance strategies. These symptoms include chronic productive cough, retention of excessive, purulent mucus in dilated airways, impairment of normal mucociliary clearance (MCC), atelectasis, breathlessness, fatigue, respiratory inflammation, fever, infection, and airflow obstruction. Airway clearance strategies may involve singular and focused interventions for the purpose of removing secretions and improving lung recruitment and gas exchange in patients with atelectasis. Strategies may also involve indirect or adjunctive interventions that facilitate or enhance effective airway clearance at different ages or stages of the disease process, for example, inhalation therapy, exercise, oxygen therapy, or noninvasive ventilation. The aim is to optimize care by selecting any one or combination of these in responding intelligently and sensitively to individual and changing patient requirements during their lifetime. Currently, a solid evidence base does not exist for airway clearance strategies in CF and non-CF bronchiectasis, and much of airway clearance clinical practice remains in the domain of clinical expertise. The paucity of evidence is partly explained by the relatively immature research machinery in allied health care internationally but is also partly to do with inadequate or inappropriate research designs. This article aims to provide an overview of the nature of, and physiological basis for, the direct and indirect airway clearance strategies in CF and non-CF bronchiectasis with reference to the best available evidence.

Keywords

physiotherapy (techniques) - cystic fibrosis - bronchiectasis - respiratory - breathing exercises - inhalation therapy - positive pressure respiration - rehabilitation
 

  • References

  • 1 Sontag MK, Quittner AL, Modi AC , et al; Investigators and Coordinators of the Airway Secretion Clearance Trial. Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis. Pediatr Pulmonol 2010; 45 (3) 291-300
    PubMedGoogle Scholar
  • 2 McIlwaine M, Wong LT, Chilvers M, Davidson GF. Long-term comparative trial of two different physiotherapy techniques; postural drainage with percussion and autogenic drainage, in the treatment of cystic fibrosis. Pediatr Pulmonol 2010; 45 (11) 1064-1069
    CrossrefPubMedGoogle Scholar
  • 3 McIlwaine MP, Alarie N, Davidson GF , et al. Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax 2013; 68 (8) 746-751
    CrossrefPubMedGoogle Scholar
  • 4 Pryor JA, Tannenbaum E, Scott SF , et al. Beyond postural drainage and percussion: Airway clearance in people with cystic fibrosis. J Cyst Fibros 2010; 9 (3) 187-192
    CrossrefPubMedGoogle Scholar
  • 5 Main E. What is the best airway clearance technique in cystic fibrosis?. Paediatr Respir Rev 2013; 14 (Suppl. 01) 10-12
    CrossrefPubMedGoogle Scholar
  • 6 Brewin CR, Bradley C. Patient preferences and randomised clinical trials. BMJ 1989; 299 (6694) 313-315
    CrossrefPubMedGoogle Scholar
  • 7 Warnock L, Gates A, van der Schans CP. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis. Cochrane Database Syst Rev 2013; 9: CD001401
    PubMedGoogle Scholar
  • 8 Elkins MR, Jones A, van der Schans C. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2006; (2) CD003147
    PubMedGoogle Scholar
  • 9 Morrison L, Agnew J. Oscillating devices for airway clearance in people with cystic fibrosis. Cochrane Database Syst Rev 2014; 7: CD006842
    PubMedGoogle Scholar
  • 10 Main E, Prasad A, Schans C. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis. Cochrane Database Syst Rev 2005; (1) CD002011
    PubMedGoogle Scholar
  • 11 McKoy NA, Saldanha IJ, Odelola OA, Robinson KA. Active cycle of breathing technique for cystic fibrosis. Cochrane Database Syst Rev 2012; 12: CD007862
    PubMedGoogle Scholar
  • 12 Murray MP, Hill AT. Non-cystic fibrosis bronchiectasis. Clin Med 2009; 9 (2) 164-169
    CrossrefPubMedGoogle Scholar
  • 13 Pryor JA. Physiotherapy for airway clearance in adults. Eur Respir J 1999; 14 (6) 1418-1424
    CrossrefPubMedGoogle Scholar
  • 14 O'Donohoe R, Fullen BM. Adherence of subjects with cystic fibrosis to their home program: a systematic review. Respir Care 2014; 59 (11) 1731-1746
    CrossrefPubMedGoogle Scholar
  • 15 Myers LB. An exploratory study investigating factors associated with adherence to chest physiotherapy and exercise in adults with cystic fibrosis. J Cyst Fibros 2009; 8 (6) 425-427
    CrossrefPubMedGoogle Scholar
  • 16 Browne WJ, Wood CJ, Desai M, Weller PH. Urinary incontinence in 9-16 year olds with cystic fibrosis compared to other respiratory conditions and a normal group. J Cyst Fibros 2009; 8 (1) 50-57
    CrossrefPubMedGoogle Scholar
  • 17 Nankivell G, Caldwell P, Follett J. Urinary incontinence in adolescent females with cystic fibrosis. Paediatr Respir Rev 2010; 11 (2) 95-99
    CrossrefPubMedGoogle Scholar
  • 18 Rees J, Tedd H, Soyza AD. Managing urinary incontinence in adults with bronchiectasis. Br J Nurs 2013; 22 (9) S15-S16 , S18
    PubMedGoogle Scholar
  • 19 Laurin LP, Jobin V, Bellemare F. Sternum length and rib cage dimensions compared with bodily proportions in adults with cystic fibrosis. Can Respir J 2012; 19 (3) 196-200
    PubMedGoogle Scholar
  • 20 Goldbeck L, Fidika A, Herle M, Quittner AL. Psychological interventions for individuals with cystic fibrosis and their families. Cochrane Database Syst Rev 2014; 6: CD003148
    PubMedGoogle Scholar
  • 21 Jamieson N, Fitzgerald D, Singh-Grewal D, Hanson CS, Craig JC, Tong A. Children's experiences of cystic fibrosis: a systematic review of qualitative studies. Pediatrics 2014; 133 (6) e1683-e1697
    CrossrefPubMedGoogle Scholar
  • 22 Cramm JM, Strating MM, Roebroeck ME, Nieboer AP. The Importance of General Self-Efficacy for the Quality of Life of Adolescents with Chronic Conditions. Soc Indic Res 2013; 113 (1) 551-561
    CrossrefPubMedGoogle Scholar
  • 23 McDonald CM, Haberman D, Brown N. Self-efficacy: empowering parents of children with cystic fibrosis. J Cyst Fibros 2013; 12 (5) 538-543
    CrossrefPubMedGoogle Scholar
  • 24 Simmons LA, Wolever RQ, Bechard EM, Snyderman R. Patient engagement as a risk factor in personalized health care: a systematic review of the literature on chronic disease. Genome Med 2014; 6 (2) 16
    CrossrefPubMedGoogle Scholar
  • 25 Lavery KA, O'Neill B, Parker M, Elborn JS, Bradley JM. Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial. Arch Phys Med Rehabil 2011; 92 (8) 1194-1201
    CrossrefPubMedGoogle Scholar
  • 26 Bott J, Blumenthal S, Buxton M , et al; British Thoracic Society Physiotherapy Guideline Development Group. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax 2009; 64 (Suppl. 01) i1-i51
    CrossrefPubMedGoogle Scholar
  • 27 Pasteur MC, Bilton D, Hill AT ; British Thoracic Society Bronchiectasis non-CF Guideline Group. British Thoracic Society guideline for non-CF bronchiectasis. Thorax 2010; 65 (Suppl. 01) i1-i58
    CrossrefPubMedGoogle Scholar
  • 28 Standards of Care and Good Clinical Practice for the Physiotherapy Management of Cystic Fibrosis. 2nd ed. London. Cystic Fibrosis Trust 2011
    Google Scholar
  • 29 Lannefors L, Button BM, McIlwaine M. Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments. J R Soc Med 2004; 97 (Suppl. 44) 8-25
    PubMedGoogle Scholar
  • 30 Barbato A, Frischer T, Kuehni CE , et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009; 34 (6) 1264-1276
    CrossrefPubMedGoogle Scholar
  • 31 Schechter MS. Airway clearance applications in infants and children. Respir Care 2007; 52 (10) 1382-1390 , discussion 1390–1391
    PubMedGoogle Scholar
  • 32 Southern KW, Munck A, Pollitt R , et al; ECFS CF Neonatal Screening Working Group. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007; 6 (1) 57-65
    CrossrefPubMedGoogle Scholar
  • 33 Massie J, Clements B ; Australian Paediatric Respiratory Group. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience—twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Pediatr Pulmonol 2005; 39 (5) 440-446
    CrossrefPubMedGoogle Scholar
  • 34 Prasad SA, Main E, Dodd ME ; Association of Chartered Physiotherapists. Finding consensus on the physiotherapy management of asymptomatic infants with cystic fibrosis. Pediatr Pulmonol 2008; 43 (3) 236-244
    CrossrefPubMedGoogle Scholar
  • 35 Prasad SA, Main E. Routine airway clearance in asymptomatic infants and babies with cystic fibrosis in the UK: obligatory or obsolete?. Phys Ther Rev 2006; 11 (1) 11-20
    CrossrefPubMedGoogle Scholar
  • 36 Rosenfeld M, Gibson RL, McNamara S , et al. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol 2001; 32 (5) 356-366
    CrossrefPubMedGoogle Scholar
  • 37 Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995; 151 (4) 1075-1082
    PubMedGoogle Scholar
  • 38 Armstrong DS, Grimwood K, Carzino R, Carlin JB, Olinsky A, Phelan PD. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis. BMJ 1995; 310 (6994) 1571-1572
    CrossrefPubMedGoogle Scholar
  • 39 Nguyen TT, Thia LP, Hoo AF , et al; London Cystic Fibrosis Collaboration (LCFC). Evolution of lung function during the first year of life in newborn screened cystic fibrosis infants. Thorax 2014; 69 (10) 910-917
    CrossrefPubMedGoogle Scholar
  • 40 Button BM, Heine RG, Catto-Smith AG, Phelan PD, Olinsky A. Chest physiotherapy, gastro-oesophageal reflux, and arousal in infants with cystic fibrosis. Arch Dis Child 2004; 89 (5) 435-439
    CrossrefPubMedGoogle Scholar
  • 41 Ewart W. The treatment of bronchiectasis and of chronic bronchial affections by posture and by respiratory exercises. Lancet 1901; 2 (4603) 70-72
    PubMedGoogle Scholar
  • 42 Lee AL, Button BM, Denehy L , et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology 2014; 19 (2) 211-217
    CrossrefPubMedGoogle Scholar
  • 43 Button BM, Heine RG, Catto-Smith AG, Phelan PD, Olinsky A. Postural drainage and gastro-oesophageal reflux in infants with cystic fibrosis. Arch Dis Child 1997; 76 (2) 148-150
    CrossrefPubMedGoogle Scholar
  • 44 Cecins NM, Jenkins SC, Pengelley J, Ryan G. The active cycle of breathing techniques—to tip or not to tip?. Respir Med 1999; 93 (9) 660-665
    CrossrefPubMedGoogle Scholar
  • 45 Eaton T, Young P, Zeng I, Kolbe J. A randomized evaluation of the acute efficacy, acceptability and tolerability of flutter and active cycle of breathing with and without postural drainage in non-cystic fibrosis bronchiectasis. Chron Respir Dis 2007; 4 (1) 23-30
    CrossrefPubMedGoogle Scholar
  • 46 Tsang S, Jones A. Postural drainage or flutter device in conjunction with breathing and coughing compared to breathing and coughing alone in improving secretion removal and lung function in patients with acute exacerbation of bronchiectasis: a pilot study. Hong Kong Physiother J 2003; 21 (1) 29-36
    CrossrefPubMedGoogle Scholar
  • 47 Currie DC, Munro C, Gaskell D, Cole PJ. Practice, problems and compliance with postural drainage: a survey of chronic sputum producers. Br J Dis Chest 1986; 80 (3) 249-253
    CrossrefPubMedGoogle Scholar
  • 48 Mazzocco MC, Owens GR, Kirilloff LH, Rogers RM. Chest percussion and postural drainage in patients with bronchiectasis. Chest 1985; 88 (3) 360-363
    CrossrefPubMedGoogle Scholar
  • 49 Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respir Med 1991; 85 (1) 45-51
    CrossrefPubMedGoogle Scholar
  • 50 Rand S, Hill L, Prasad SA. Physiotherapy in cystic fibrosis: optimising techniques to improve outcomes. Paediatr Respir Rev 2013; 14 (4) 263-269
    PubMedGoogle Scholar
  • 51 McCarren B, Alison JA. Physiological effects of vibration in subjects with cystic fibrosis. Eur Respir J 2006; 27 (6) 1204-1209
    CrossrefPubMedGoogle Scholar
  • 52 Pryor JA, Webber BA, Hodson ME, Batten JC. Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. BMJ 1979; 2 (6187) 417-418
    CrossrefPubMedGoogle Scholar
  • 53 Webber BA, Pryor JA. Respiratory physiotherapy for cystic fibrosis. J Pediatr 1989; 115 (1) 167-168
    PubMedGoogle Scholar
  • 54 Volpe MS, Adams AB, Amato MB, Marini JJ. Ventilation patterns influence airway secretion movement. Respir Care 2008; 53 (10) 1287-1294
    PubMedGoogle Scholar
  • 55 Flude LJ, Agent P, Bilton D. Chest physiotherapy techniques in bronchiectasis. Clin Chest Med 2012; 33 (2) 351-361
    CrossrefPubMedGoogle Scholar
  • 56 Fink JB. Forced expiratory technique, directed cough, and autogenic drainage. Respir Care 2007; 52 (9) 1210-1221 , discussion 1221–1223
    PubMedGoogle Scholar
  • 57 Hasani A, Pavia D, Agnew JE, Clarke SW. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity. Thorax 1994; 49 (6) 557-561
    CrossrefPubMedGoogle Scholar
  • 58 Phillips GE, Pike SE, Jaffé A, Bush A. Comparison of active cycle of breathing and high-frequency oscillation jacket in children with cystic fibrosis. Pediatr Pulmonol 2004; 37 (1) 71-75
    CrossrefPubMedGoogle Scholar
  • 59 O'Neill B, Bradley JM, McArdle N, MacMahon J. The current physiotherapy management of patients with bronchiectasis: a UK survey. Int J Clin Pract 2002; 56 (1) 34-35
    PubMedGoogle Scholar
  • 60 Thompson CS, Harrison S, Ashley J, Day K, Smith DL. Randomised crossover study of the Flutter device and the active cycle of breathing technique in non-cystic fibrosis bronchiectasis. Thorax 2002; 57 (5) 446-448
    CrossrefPubMedGoogle Scholar
  • 61 Lee AL, Burge A, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2013; 5: CD008351
    PubMedGoogle Scholar
  • 62 Sutton PP, Gemmell HG, Innes N , et al. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Thorax 1988; 43 (1) 57-60
    CrossrefPubMedGoogle Scholar
  • 63 Patterson JE, Bradley JM, Elborn JS. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques (incorporating postural drainage and vibration) versus test of incremental respiratory endurance. Chron Respir Dis 2004; 1 (3) 127-130
    CrossrefPubMedGoogle Scholar
  • 64 Patterson JE, Bradley JM, Hewitt O, Bradbury I, Elborn JS. Airway clearance in bronchiectasis: a randomized crossover trial of active cycle of breathing techniques versus Acapella. Respiration 2005; 72 (3) 239-242
    CrossrefPubMedGoogle Scholar
  • 65 Dab I, Alexander F. The mechanism of autogenic drainage studied with flow volume curves. Monogr Paediatr 1979; 10: 50-53
    PubMedGoogle Scholar
  • 66 App EM, Kieselmann R, Reinhardt D , et al. Sputum rheology changes in cystic fibrosis lung disease following two different types of physiotherapy: flutter vs autogenic drainage. Chest 1998; 114 (1) 171-177
    CrossrefPubMedGoogle Scholar
  • 67 Pfleger A, Theissl B, Oberwaldner B, Zach MS. Self-administered chest physiotherapy in cystic fibrosis: a comparative study of high-pressure PEP and autogenic drainage. Lung 1992; 170 (6) 323-330
    PubMedGoogle Scholar
  • 68 Giles DR, Wagener JS, Accurso FJ, Butler-Simon N. Short-term effects of postural drainage with clapping vs autogenic drainage on oxygen saturation and sputum recovery in patients with cystic fibrosis. Chest 1995; 108 (4) 952-954
    CrossrefPubMedGoogle Scholar
  • 69 Miller S, Hall DO, Clayton CB, Nelson R. Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage. Thorax 1995; 50 (2) 165-169
    CrossrefPubMedGoogle Scholar
  • 70 Van Ginderdeuren F, Verbanck S, Van Cauwelaert K , et al. Chest physiotherapy in cystic fibrosis: short-term effects of autogenic drainage preceded by wet inhalation of saline versus autogenic drainage preceded by intrapulmonary percussive ventilation with saline. Respiration 2008; 76 (2) 175-180
    CrossrefPubMedGoogle Scholar
  • 71 Geller D. The science of aerosol delivery in cystic fibrosis. Pediatr Pulmonol 2008; 43 (S9): S5-S17
    CrossrefPubMedGoogle Scholar
  • 72 Silverman WA, Altman DG. Patients' preferences and randomised trials. Lancet 1996; 347 (8995) 171-174
    CrossrefPubMedGoogle Scholar
  • 73 O'Connor C, Bridge P. Can the Interrupter Technique be used as an Outcome Measure for Autogenic Drainage in Bronchiectatic Patients? A Pilot Study. Journal of the Association of Chartered Physiotherapists in Respiratory Care 2005; 37: 29-34
    PubMedGoogle Scholar
  • 74 Savci S, Ince DI, Arikan H. A comparison of autogenic drainage and the active cycle of breathing techniques in patients with chronic obstructive pulmonary diseases. J Cardiopulm Rehabil 2000; 20 (1) 37-43
    CrossrefPubMedGoogle Scholar
  • 75 Van Ginderdeuren F, Malfroot A, Verdonck J. Influence of assisted autogenic drainage (AAD) and AAD combined with bouncing on gastro-oesophageal reflux (GOR) in infants under the age of 5 months. J Cystic Fibrosis 2003; 2 (Suppl. 01) A251
    PubMedGoogle Scholar
  • 76 Andersen JB, Qvist J, Kann T. Recruiting collapsed lung through collateral channels with positive end-expiratory pressure. Scand J Respir Dis 1979; 60 (5) 260-266
    PubMedGoogle Scholar
  • 77 Groth S, Stafanger G, Dirksen H, Andersen JB, Falk M, Kelstrup M. Positive expiratory pressure (PEP-mask) physiotherapy improves ventilation and reduces volume of trapped gas in cystic fibrosis. Bull Eur Physiopathol Respir 1985; 21 (4) 339-343
    PubMedGoogle Scholar
  • 78 Falk M, Kelstrup M, Andersen JB , et al. Improving the ketchup bottle method with positive expiratory pressure, PEP, in cystic fibrosis. Eur J Respir Dis 1984; 65 (6) 423-432
    PubMedGoogle Scholar
  • 79 West K, Wallen M, Follett J. Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation. Physiother Theory Pract 2010; 26 (3) 143-149
    CrossrefPubMedGoogle Scholar
  • 80 Braggion C, Cappelletti LM, Cornacchia M, Zanolla L, Mastella G. Short-term effects of three chest physiotherapy regimens in patients hospitalized for pulmonary exacerbations of cystic fibrosis: a cross-over randomized study. Pediatr Pulmonol 1995; 19 (1) 16-22
    PubMedGoogle Scholar
  • 81 Lannefors L, Wollmer P. Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and physical exercise. Eur Respir J 1992; 5 (6) 748-753
    PubMedGoogle Scholar
  • 82 McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997; 131 (4) 570-574
    CrossrefPubMedGoogle Scholar
  • 83 McIlwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of positive expiratory pressure versus oscillating positive expiratory pressure (flutter) physiotherapy in the treatment of cystic fibrosis. J Pediatr 2001; 138 (6) 845-850
    CrossrefPubMedGoogle Scholar
  • 84 Valente AM, Gastaldi AC, Cravo SL, Afonso JL, Sologuren MJJ, Guimaraes RC. The effect of two techniques on the characteristics and transport of sputum in patients with bronchiectasis. A pilot study. Physiotherapy 2004; 90 (3) 158-164
    CrossrefPubMedGoogle Scholar
  • 85 Costantini D, Brivio A, Brusa D, Delfino R, Fredella C, Russo M. PEP-mask versus postural drainage in CF infants a long-term comparative trial. Pediatric Pulmonology 2001; 32 (Suppl. 22) 308
    CrossrefPubMedGoogle Scholar
  • 86 Heine RG, Button BM, Olinsky A, Phelan PD, Catto-Smith AG. Gastro-oesophageal reflux in infants under 6 months with cystic fibrosis. Arch Dis Child 1998; 78 (1) 44-48
    CrossrefPubMedGoogle Scholar
  • 87 Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. J Pediatr 1994; 124 (5, Pt 1) 689-693
    CrossrefPubMedGoogle Scholar
  • 88 van Winden CM, Visser A, Hop W, Sterk PJ, Beckers S, de Jongste JC. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis. Eur Respir J 1998; 12 (1) 143-147
    CrossrefPubMedGoogle Scholar
  • 89 Padman R, Geouque DM, Engelhardt MT. Effects of the flutter device on pulmonary function studies among pediatric cystic fibrosis patients. Del Med J 1999; 71 (1) 13-18
    PubMedGoogle Scholar
  • 90 Newbold ME, Tullis E, Corey M, Ross B, Brooks D. The flutter device versus the PEP mask in the treatment of adults with cystic fibrosis. Physiother Can 2005; 57: 199-207
    CrossrefPubMedGoogle Scholar
  • 91 Volsko TA, DiFiore J, Chatburn RL. Performance comparison of two oscillating positive expiratory pressure devices: Acapella versus Flutter. Respir Care 2003; 48 (2) 124-130
    PubMedGoogle Scholar
  • 92 Guimarães FS, Moço VJ, Menezes SL, Dias CM, Salles RE, Lopes AJ. Effects of ELTGOL and Flutter VRP1® on the dynamic and static pulmonary volumes and on the secretion clearance of patients with bronchiectasis. Rev Bras Fisioter 2012; 16 (2) 108-113
    CrossrefPubMedGoogle Scholar
  • 93 Naraparaju S, Vaishali K, Venkatesan P, Acharya V. A comparison of the Acapella and a threshold inspiratory muscle trainer for sputum clearance in bronchiectasis-A pilot study. Physiother Theory Pract 2010; 26 (6) 353-357
    CrossrefPubMedGoogle Scholar
  • 94 Figueiredo PH, Zin WA, Guimarães FS. Flutter valve improves respiratory mechanics and sputum production in patients with bronchiectasis. Physiother Res Int 2012; 17 (1) 12-20
    CrossrefPubMedGoogle Scholar
  • 95 Murray MP, Pentland JL, Hill AT. A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis. Eur Respir J 2009; 34 (5) 1086-1092
    CrossrefPubMedGoogle Scholar
  • 96 Lee AL, Williamson HC, Lorensini S, Spencer LM. The effects of oscillating positive expiratory pressure therapy in adults with stable non-cystic fibrosis bronchiectasis: a systematic review. Chron Respir Dis 2014;
    PubMedGoogle Scholar
  • 97 Mestriner RG, Fernandes RO, Steffen LC, Donadio MV. Optimum design parameters for a therapist-constructed positive-expiratory-pressure therapy bottle device. Respir Care 2009; 54 (4) 504-508
    PubMedGoogle Scholar
  • 98 Darbee JC, Kanga JF, Ohtake PJ. Physiologic evidence for high-frequency chest wall oscillation and positive expiratory pressure breathing in hospitalized subjects with cystic fibrosis. Phys Ther 2005; 85 (12) 1278-1289
    PubMedGoogle Scholar
  • 99 Oermann CM, Sockrider MM, Giles D, Sontag MK, Accurso FJ, Castile RG. Comparison of high-frequency chest wall oscillation and oscillating positive expiratory pressure in the home management of cystic fibrosis: a pilot study. Pediatr Pulmonol 2001; 32 (5) 372-377
    CrossrefPubMedGoogle Scholar
  • 100 Warwick WJ, Hansen LG. The long-term effect of high-frequency chest compression therapy on pulmonary complications of cystic fibrosis. Pediatr Pulmonol 1991; 11 (3) 265-271
    CrossrefPubMedGoogle Scholar
  • 101 Osman LP, Roughton M, Hodson ME, Pryor JA. Short-term comparative study of high frequency chest wall oscillation and European airway clearance techniques in patients with cystic fibrosis. Thorax 2010; 65 (3) 196-200
    CrossrefPubMedGoogle Scholar
  • 102 Gokdemir Y, Karadag-Saygi E, Erdem E , et al. Comparison of conventional pulmonary rehabilitation and high-frequency chest wall oscillation in primary ciliary dyskinesia. Pediatr Pulmonol 2014; 49 (6) 611-616
    CrossrefPubMedGoogle Scholar
  • 103 Nicolini A, Cardini F, Landucci N, Lanata S, Ferrari-Bravo M, Barlascini C. Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis. BMC Pulm Med 2013; 13: 21
    CrossrefPubMedGoogle Scholar
  • 104 Mahajan AK, Diette GB, Hatipoğlu U , et al. High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial. Respir Res 2011; 12: 120
    CrossrefPubMedGoogle Scholar
  • 105 Fauroux B, Boulé M, Lofaso F , et al. Chest physiotherapy in cystic fibrosis: improved tolerance with nasal pressure support ventilation. Pediatrics 1999; 103 (3) E32
    CrossrefPubMedGoogle Scholar
  • 106 Holland AE, Denehy L, Ntoumenopoulos G, Naughton MT, Wilson JW. Non-invasive ventilation assists chest physiotherapy in adults with acute exacerbations of cystic fibrosis. Thorax 2003; 58 (10) 880-884
    CrossrefPubMedGoogle Scholar
  • 107 Moran F, Bradley JM, Piper AJ. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst Rev 2009; (1) CD002769
    PubMedGoogle Scholar
  • 108 Young AC, Wilson JW, Kotsimbos TC, Naughton MT. Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax 2008; 63 (1) 72-77
    CrossrefPubMedGoogle Scholar
  • 109 Flight WG, Shaw J, Johnson S , et al. Long-term non-invasive ventilation in cystic fibrosis — experience over two decades. J Cyst Fibros 2012; 11 (3) 187-192
    CrossrefPubMedGoogle Scholar
  • 110 Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur Respir J 1997; 10 (9) 1999-2003
    CrossrefPubMedGoogle Scholar
  • 111 Lima CA, de Andrade AdeF, Campos SL , et al. Effects of noninvasive ventilation on treadmill 6-min walk distance and regional chest wall volumes in cystic fibrosis: randomized controlled trial. Respir Med 2014; 108 (10) 1460-1468
    CrossrefPubMedGoogle Scholar
  • 112 Paneroni M, Clini E, Simonelli C, Bianchi L, Degli Antoni F, Vitacca M. Safety and efficacy of short-term intrapulmonary percussive ventilation in patients with bronchiectasis. Respir Care 2011; 56 (7) 984-988
    CrossrefPubMedGoogle Scholar
  • 113 Sivasothy P, Brown L, Smith IE, Shneerson JM. Effect of manually assisted cough and mechanical insufflation on cough flow of normal subjects, patients with chronic obstructive pulmonary disease (COPD), and patients with respiratory muscle weakness. Thorax 2001; 56 (6) 438-444
    CrossrefPubMedGoogle Scholar
  • 114 Bradley J, Moran F. Physical training for cystic fibrosis. Cochrane Database Syst Rev 2008; (1) CD002768
    PubMedGoogle Scholar
  • 115 Dwyer TJ, Alison JA, McKeough ZJ, Daviskas E, Bye PT. Effects of exercise on respiratory flow and sputum properties in patients with cystic fibrosis. Chest 2011; 139 (4) 870-877
    CrossrefPubMedGoogle Scholar
  • 116 Kim CS, Rodriguez CR, Eldridge MA, Sackner MA. Criteria for mucus transport in the airways by two-phase gas-liquid flow mechanism. J Appl Physiol (1985) 1986; 60 (3) 901-907
    CrossrefPubMedGoogle Scholar
  • 117 Hebestreit A, Kersting U, Basler B, Jeschke R, Hebestreit H. Exercise inhibits epithelial sodium channels in patients with cystic fibrosis. Am J Respir Crit Care Med 2001; 164 (3) 443-446
    CrossrefPubMedGoogle Scholar
  • 118 Daviskas E, Anderson SD, Gonda I, Chan HK, Cook P, Fulton R. Changes in mucociliary clearance during and after isocapnic hyperventilation in asthmatic and healthy subjects. Eur Respir J 1995; 8 (5) 742-751
    PubMedGoogle Scholar
  • 119 Kim CS, Iglesias AJ, Sackner MA. Mucus clearance by two-phase gas-liquid flow mechanism: asymmetric periodic flow model. J Appl Physiol (1985) 1987; 62 (3) 959-971
    CrossrefPubMedGoogle Scholar
  • 120 Ries AL, Bauldoff GS, Carlin BW , et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007; 131 (5, Suppl): 4S-42S
    CrossrefPubMedGoogle Scholar
  • 121 ZuWallack R, Hedges H. Primary care of the patient with chronic obstructive pulmonary disease-part 3: pulmonary rehabilitation and comprehensive care for the patient with chronic obstructive pulmonary disease. Am J Med 2008; 121 (7, Suppl): S25-S32
    CrossrefPubMedGoogle Scholar
  • 122 Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005; 60 (11) 943-948
    CrossrefPubMedGoogle Scholar
  • 123 Bradley J, Moran F, Greenstone M. Physical training for bronchiectasis. Cochrane Database Syst Rev 2002; (3) CD002166
    PubMedGoogle Scholar
  • 124 Bilton D, Dodd ME, Abbot JV, Webb AK. The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis. Respir Med 1992; 86 (6) 507-511
    CrossrefPubMedGoogle Scholar
  • 125 Salh W, Bilton D, Dodd M, Webb AK. Effect of exercise and physiotherapy in aiding sputum expectoration in adults with cystic fibrosis. Thorax 1989; 44 (12) 1006-1008
    CrossrefPubMedGoogle Scholar
  • 126 Bilton D, Stanford G. The expanding armamentarium of drugs to aid sputum clearance: how should they be used to optimize care?. Curr Opin Pulm Med 2014; 20 (6) 601-606
    PubMedGoogle Scholar
  • 127 Balsamo R, Lanata L, Egan CG. Mucoactive drugs. Eur Respir Rev 2010; 19 (116) 127-133
    CrossrefPubMedGoogle Scholar
  • 128 Tomkiewicz RP, App EM, De Sanctis GT , et al. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog. Pulm Pharmacol 1995; 8 (6) 259-265
    CrossrefPubMedGoogle Scholar
  • 129 Bilton D, Tino G, Barker AF , et al; B-305 Study Investigators. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial. Thorax 2014; 69 (12) 1073-1079
    CrossrefPubMedGoogle Scholar
  • 130 Williams R, Rankin N, Smith T, Galler D, Seakins P. Relationship between the humidity and temperature of inspired gas and the function of the airway mucosa. Crit Care Med 1996; 24 (11) 1920-1929
    CrossrefPubMedGoogle Scholar
  • 131 Conway JH, Fleming JS, Perring S, Holgate ST. Humidification as an adjunct to chest physiotherapy in aiding tracheo-bronchial clearance in patients with bronchiectasis. Respir Med 1992; 86 (2) 109-114
    CrossrefPubMedGoogle Scholar
  • 132 Hasani A, Chapman TH, McCool D, Smith RE, Dilworth JP, Agnew JE. Domiciliary humidification improves lung mucociliary clearance in patients with bronchiectasis. Chron Respir Dis 2008; 5 (2) 81-86
    CrossrefPubMedGoogle Scholar
  • 133 Mall MA, Harkema JR, Trojanek JB , et al. Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice. Am J Respir Crit Care Med 2008; 177 (7) 730-742
    CrossrefPubMedGoogle Scholar
  • 134 Rea H, McAuley S, Jayaram L , et al. The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010; 104 (4) 525-533
    CrossrefPubMedGoogle Scholar
  • 135 Shak S. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest 1995; 107 (2, Suppl): 65S-70S
    CrossrefPubMedGoogle Scholar
  • 136 Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev 2010; (3) CD001127
    PubMedGoogle Scholar
  • 137 Frederiksen B, Pressler T, Hansen A, Koch C, Høiby N. Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization in patients with cystic fibrosis. Acta Paediatr 2006; 95 (9) 1070-1074
    CrossrefPubMedGoogle Scholar
  • 138 Berge MT, Wiel Ev, Tiddens HA, Merkus PJ, Hop WC, de Jongste JC. DNase in stable cystic fibrosis infants: a pilot study. J Cyst Fibros 2003; 2 (4) 183-188
    CrossrefPubMedGoogle Scholar
  • 139 Goss CH, MacNeill SJ, Quinton HB , et al. Children and young adults with CF in the USA have better lung function compared with the UK. Thorax 2014; . doi: 10.1136/thoraxjnl-2014-205718 [Epub ahead of print]
    PubMedGoogle Scholar
  • 140 O'Donnell AE, Barker AF, Ilowite JS, Fick RB. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. Chest 1998; 113 (5) 1329-1334
    CrossrefPubMedGoogle Scholar
  • 141 Wills PJ, Wodehouse T, Corkery K, Mallon K, Wilson R, Cole PJ. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am J Respir Crit Care Med 1996; 154 (2, Pt 1) 413-417
    CrossrefPubMedGoogle Scholar
  • 142 Wilkinson M, Sugumar K, Milan SJ, Hart A, Crockett A, Crossingham I. Mucolytics for bronchiectasis. Cochrane Database Syst Rev 2014; 5: CD001289
    PubMedGoogle Scholar
  • 143 Elkins MR, Robinson M, Rose BR , et al; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med 2006; 354 (3) 229-240
    CrossrefPubMedGoogle Scholar
  • 144 Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest 1997; 99 (1) 9-13
    CrossrefPubMedGoogle Scholar
  • 145 Robinson M, Hemming AL, Regnis JA , et al. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis. Thorax 1997; 52 (10) 900-903
    CrossrefPubMedGoogle Scholar
  • 146 Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996; 21 (2) 77-83
    CrossrefPubMedGoogle Scholar
  • 147 Amin R, Subbarao P, Jabar A , et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010; 65 (5) 379-383
    CrossrefPubMedGoogle Scholar
  • 148 Subbarao P, Balkovec S, Solomon M, Ratjen F. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatr Pulmonol 2007; 42 (5) 471-476
    CrossrefPubMedGoogle Scholar
  • 149 Dellon EP, Donaldson SH, Johnson R, Davis SD. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol 2008; 43 (11) 1100-1106
    CrossrefPubMedGoogle Scholar
  • 150 Rosenfeld M, Ratjen F, Brumback L , et al; ISIS Study Group. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012; 307 (21) 2269-2277
    CrossrefPubMedGoogle Scholar
  • 151 Kellett F, Robert NM. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir Med 2011; 105 (12) 1831-1835
    CrossrefPubMedGoogle Scholar
  • 152 Nicolson CH, Stirling RG, Borg BM, Button BM, Wilson JW, Holland AE. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis. Respir Med 2012; 106 (5) 661-667
    CrossrefPubMedGoogle Scholar
  • 153 Chang AB, Bell SC, Byrnes CA , et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand. Med J Aust 2010; 193 (6) 356-365
    PubMedGoogle Scholar
  • 154 Hart A, Sugumar K, Milan SJ, Fowler SJ, Crossingham I. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2014; 5: CD002996
    PubMedGoogle Scholar
  • 155 Amin R, Ratjen F. Emerging drugs for cystic fibrosis. Expert Opin Emerg Drugs 2014; 19 (1) 143-155
    CrossrefPubMedGoogle Scholar
  • 156 Wills P, Greenstone M. Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev 2006; (2) CD002996
    PubMedGoogle Scholar
  • 157 Bilton D, Bellon G, Charlton B , et al; CF301 and CF302 Investigators. Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis. J Cyst Fibros 2013; 12 (4) 367-376
    CrossrefPubMedGoogle Scholar
  • 158 Daniels T. Physiotherapeutic management strategies for the treatment of cystic fibrosis in adults. J Multidiscip Healthc 2010; 3: 201-212
    PubMedGoogle Scholar
  • 159 Daniels T, Mills N, Whitaker P. Nebuliser systems for drug delivery in cystic fibrosis. Cochrane Database Syst Rev 2013; 4: CD007639
    PubMedGoogle Scholar
  • 160 Dentice R, Elkins M. Timing of dornase alfa inhalation for cystic fibrosis. Cochrane Database Syst Rev 2011; (5) CD007923
    PubMedGoogle Scholar
  • 161 Elkins M, Dentice R. Timing of hypertonic saline inhalation for cystic fibrosis. Cochrane Database Syst Rev 2012; 2: CD008816
    PubMedGoogle Scholar
  • 162 Daviskas E, Anderson SD, Eberl S, Chan HK, Young IH. The 24-h effect of mannitol on the clearance of mucus in patients with bronchiectasis. Chest 2001; 119 (2) 414-421
    CrossrefPubMedGoogle Scholar
  • 163 Burness CB, Keating GM. Mannitol dry powder for inhalation: in patients with cystic fibrosis. Drugs 2012; 72 (10) 1411-1421
    CrossrefPubMedGoogle Scholar
  • 164 Daviskas E, Rubin BK. Effect of inhaled dry powder mannitol on mucus and its clearance. Expert Rev Respir Med 2013; 7 (1) 65-75
    CrossrefPubMedGoogle Scholar
  • 165 Elkins MR, Anderson SD, Perry CP, Daviskas E, Charlton B. Inspiratory Flows and Volumes in Subjects with Non-CF Bronchiectasis Using a New Dry Powder Inhaler Device. Open Respir Med J 2014; 8: 8-13
    CrossrefPubMedGoogle Scholar
  • 166 Elkins MR, Robinson P, Anderson SD, Perry CP, Daviskas E, Charlton B. Inspiratory flows and volumes in subjects with cystic fibrosis using a new dry powder inhaler device. Open Respir Med J 2014; 8: 1-7
    CrossrefPubMedGoogle Scholar
  • 167 Collins N. Nebulizer therapy in cystic fibrosis: an overview. J R Soc Med 2009; 102 (Suppl. 01) 11-17
    PubMedGoogle Scholar
  • 168 Quittner AL, Modi AC, Lemanek KL, Ievers-Landis CE, Rapoff MA. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol 2008; 33 (9) 916-936 , discussion 937–938
    CrossrefPubMedGoogle Scholar
  • 169 Glasscoe CA, Quittner AL. Psychological interventions for people with cystic fibrosis and their families. Cochrane Database Syst Rev 2008; (3) CD003148
    PubMedGoogle Scholar
  • 170 Daniels T. Nebuliser systems for drug delivery in cystic fibrosis. J Evid Based Med 2013; 6 (3) 201
    CrossrefPubMedGoogle Scholar
  • 171 Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011; 140 (2) 425-432
    CrossrefPubMedGoogle Scholar